Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preoperative roxithromycin for chronic rhinosinusitis surgery
ACTRN12611000485932Phase 4Not yet recruiting
- Sponsor
- The Royal Victorian Eye and Ear Hospital
- Start
- Jun 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of roxithromycin in chronic rhinosinusitis (CRS) (2 arms), sponsored by The Royal Victorian Eye and Ear Hospital. Primary endpoint: Surgical field grade. Planned start Jun 2011; status: not yet recruiting.
02
Drugs
roxithromycin
03
Conditions
chronic rhinosinusitis (CRS)
Beyond the preview
Go deeper on ACTRN12611000485932.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12611000485932.